|
Bulk drug and intermediates exports grew over 14% in August
|
|
Gireesh Babu, New Delhi
October 14 , 2025
|
|
|
Exports of bulk drugs and intermediates grew more than 14% in the month of August, this year, reporting a trade surplus of $15.58 million for the month.
Exports during the month of August, 2025, stood at $405.45 million, as compared to $354.91 million in the same month of previous year. The exports in August, 2024 was around 6.3% decline from $378.97 million in the same month of 2023, according to data from the ministry of commerce and industry.
In Rupee terms, the exports were around 19.17% higher in August, 2025 at Rs. 3,548.4 crore as compared to Rs. 2,977.6 crore in the same month of previous year. The export in August, 2024 was a 5.09% decline compared to Rs. 3,137.3 crore in August, 2023.
As reported earlier, the imports of bulk drugs and intermediates during the month was at $389.87 million, which was a 0.94% decline from the same month of last year.
Quantity of exports grew around 26% in August, 2025, at 41,308.2 MT of bulk drugs and intermediates, as compared to 32,801.7 MT in the same month last year.
During the five month ended August 31, 2025, the exports grew 8.60% to $2.02 billion, as compared to $1.86 billion in the same period of previous fiscal year. The exports during April to August, 2024 was 2.7% decline compared to $1.91 billion during the same period of April to August, 2023.
In Rupee terms, the exports were 11.73% higher at Rs 17,401.13 crore during the five months till August 31, 2025, as compared to Rs. 15,574.7 crore in the same period a year ago.
In terms of quantity, the exports of bulk drugs and intermediates grew 12.44% to 2,04,978.7 MT during five months ended August 31, 2025, as against 1,82,286.2 MT reported in the same period of previous financial year.
It may be noted that the exports during the financial year ended March, 2025 reported a 2.3% growth to $4.9 billion, as compared to $4.79 billion in the previous fiscal year. Quantity, on the other hand, declined 3.2% to 4,59,449 MT as compared to 4,74,617 MT reported during April, 2023 to March, 2024.
As reported earlier, imports of bulk drugs and intermediates to India registered a marginal decline of close to 1% in the month of August, 2025, while the cumulative imports for the first five months of the fiscal year witnessed a decline of 3.6%.
The imports during the month of August stood at $389.87 million, as compared to $393.59 million in the same month of last year.
In Rupee terms, imports registered a growth of 3.33% in August, at Rs. 3,412.13 crore as compared to Rs. 3,302.08 crore reported in the corresponding month of previous fiscal year.
Quantity of imports reported a decline of 7.5% at 39,454 MT during the month, as against 42,652 MT in August, 2024. The imports during August, 2024 was a growth of 2.40% from 41,653 MT reported in the month of August, 2023.
The Central government has been emphasising on reducing the imports of essential pharmaceutical raw materials such as bulk drugs, drug intermediates and key starting materials, among others, and has initiated various incentive schemes to support domestic production of these materials.
The Department of Pharmaceuticals has been promoting production of pharma raw materials in the country, including through a production linked incentive (PLI) scheme for promotion of domestic manufacturing of critical key starting materials (KSMs)/drug intermediates and active pharmaceutical ingredients (APIs) in the country, to support the industry in various aspects regarding ease of doing business and availing the benefits of the Scheme.
It has also announced schemes to promote bulk drug parks in the country, as part of its efforts to promote domestic manufacturing of pharma ingredients.
|
|
|
|
|
|
|
|
TOPICS
|
The Food and Drug Administration (FDA), Maharashtra, has issued a public advisory urging citizens to report any misleadi ...
|
|
|
|
|